Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase vs Alteplase Before Thrombectomy in Large Vessel Occlusion Stroke
2020-001599-13Phase 3Active
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in ischemic stroke comparing Tenecteplase arm with Alteplase arm (2 arms). Primary endpoint: Shift analysis of the modified Rankin Scale at 3 months. Started Aug 2021; status: active.
02
Drugs
tenecteplasetissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2020-001599-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001599-13.